The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months

OBJECTIVE: We developed a scale to serve as a potential end point for 6-month glycemic progression (PS6M) toward type 1 diabetes (T1D) in autoantibody-positive relatives of individuals with T1D. RESEARCH DESIGN AND METHODS: The PS6M was developed from Diabetes Prevention Trial–Type 1 (DPT-1) data an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Sosenko, Jay M., Skyler, Jay S., Beam, Craig A., Boulware, David, Mahon, Jeffrey L., Krischer, Jeffrey P., Greenbaum, Carla J., Rafkin, Lisa E., Matheson, Della, Herold, Kevan C., Palmer, Jerry P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2015
Assuntos:
Novel Communications in Diabetes
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4407750/
https://ncbi.nlm.nih.gov/pubmed/25758770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc14-2787
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados